Navigation Links
Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team
Date:5/22/2013

Blue Earth, MN (PRWEB) May 22, 2013

Express Diagnostics Int’l, Inc. (EDI), and Royal Medical Supplies Pty Ltd are pleased to announce a sponsorship agreement with Erebus Motorsport V8. Royal Medical is the Australian and New Zealand distributor of DrugCheck® onsite testing devices, manufactured by EDI. The Erebus Motorsport V8 Supercar Team participated in the Austin 400 May 17-19 in Austin, Texas.

Royal Medical Supplies has entered into an agreement that involves each car of the Erebus Motorsport team displaying the Royal Medical name and logo in Australian racing events. Erebus owns and races three Mercedes-Benz E63 AMG V8 Supercars in the Australian V8 Supercar series — the Australian equivalent to the American NASCAR® series. For races held in the U.S., the team’s cars will also display the DrugCheck logo.

"We're very excited about partnering with Erebus Motorsport, which races the Mercedes-Benz AMG, a new make of race car for the V8 Supercar series,” says Gavin Holland, director of Royal Medical Supplies. “This motor racing championship appeals to a high proportion of Australians and New Zealanders and our target customers will be able to enjoy some of the on-track and off-track benefits resulting from this arrangement. The cars competing in the championship held in Austin, Texas, displayed the DrugCheck logo as well, providing additional media and on-track exposure for the brand.”

While sports team and event sponsorship is new to Express Diagnostics, the company welcomes Royal Medical’s efforts to raise the visibility of the DrugCheck brand. “We value our partnership with Royal Medical Supplies and appreciate Gavin’s commitment to promoting this U.S.-made product,” says Rich Strasser, COO of Express Diagnostics. “It was exciting to see the DrugCheck logo on the Erebus Motorsport cars during the Austin 400. We’d like to thank Royal Medical both for their sponsorship of the team and their continued support.”

Erebus Motorsport next races in the Skycity Triple Crown June 14-16 in Darwin, Australia.

About Express Diagnostics Int’l, Inc.
Express Diagnostics Int’l manufactures and distributes DrugCheck® on-site urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of health screening devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. Learn more at drugcheck.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10754553.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Tom Karagiannis, Ph.D. Awarded Future Fellowship by Australian Research Council (ARC)
2. Australian Discovered Biomarkers Map Path to New Blood Test for Bowel Cancer
3. Algae.Tec Announces Commencement of Australian Advanced Biofuels Facility Commissioning
4. Hemaclear Announces First Annual Italian Distributor and User Conference: May 22, 2013 in Rome, Italy
5. Vertilon Signs Crisel Instruments as its Distributor in Italy
6. Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor
7. JG Finneran Associates Appoints Chebios as its Exclusive Distributor in Italy
8. UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
9. Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck
10. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
11. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):